BioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

bioAffinity Technologies, Inc. , a biotechnology company focused on commercializing noninvasive tests for the detection of early-stage cancer and lung disease, today reported financial results for...

Related Keywords

Pennsylvania ,United States ,Texas ,American ,America ,Jamie Platt ,Sandeep Bansal ,Michael Dougherty ,Maria Zannes ,While The Company ,Company Annual Report On Form ,Affinity Technologies Inc ,Laboratory Developed Test ,Medicaid Services ,Precision Pathology Services ,Company Board Of Directors ,Nasdaq ,Pennsylvania Lung Innovations Network ,Precision Pathology Laboratory Services ,Facebook ,College Of American Pathologists ,Department Of Defense ,Centers For Medicare ,Linkedin ,Dallas Coleman As National ,Affinity Technologies ,Chief Financial Officer ,Alexa Commercial ,Dallas Coleman ,National Director ,Executive Account Manager ,Olympus America ,American Pathologists ,Precision Pathology Laboratory ,Scientific Advisory Board ,Medical Director ,Lung Innovations Network ,Managing Director ,Chief Executive Officer ,Pictor Limited ,Precision Pathology ,Annual Report ,Years Ended December ,Markets ,